Cite
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations.
MLA
Hertz, Daniel L., et al. “Paclitaxel Therapeutic Drug Monitoring - International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations.” European Journal of Cancer (Oxford, England : 1990), vol. 202, May 2024, p. 114024. EBSCOhost, https://doi.org/10.1016/j.ejca.2024.114024.
APA
Hertz, D. L., Joerger, M., Bang, Y.-J., Mathijssen, R. H., Zhou, C., Zhang, L., Gandara, D., Stahl, M., Monk, B. J., Jaehde, U., & Beumer, J. H. (2024). Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations. European Journal of Cancer (Oxford, England : 1990), 202, 114024. https://doi.org/10.1016/j.ejca.2024.114024
Chicago
Hertz, Daniel L, Markus Joerger, Yung-Jue Bang, Ron H Mathijssen, Caicun Zhou, Li Zhang, David Gandara, et al. 2024. “Paclitaxel Therapeutic Drug Monitoring - International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations.” European Journal of Cancer (Oxford, England : 1990) 202 (May): 114024. doi:10.1016/j.ejca.2024.114024.